MedTrace Logo

Investigation of Genetic Risk of Metabolic Syndrome in Company Employee (NGK Study)

NCT00408824 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 4000

Last updated 2007-09-20

No results posted yet for this study

Summary

The metabolic syndrome is a highly prevalent disorder, which causes atherosclerotic cardiovascular disease and is closely associated with insulin resistance. The alteration of the secretion of adipocytokines from accumulated visceral adipose tissue in the obese induces insulin resistance. The purpose of this study is to identify gene polymorphisms that confer susceptibility to the metabolic syndrome and to make up a new health guidance program based on genetic risk assessment. About 25% of male employees over 45 years old in a certain company are diagnosed with the metabolic syndrome in medical examination. We, the researchers at Nagoya University, will analyze gene polymorphism and various biomarkers of over 3500 company employees.

Conditions

Sponsors & Collaborators

  • Nagoya University

    lead OTHER

Principal Investigators

  • Kenji Yasui, MD, PhD · Department of Bio-information Analysis, Research Institute of Environmental Medicine, Nagoya University

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-09-30

Countries

  • Japan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00408824 on ClinicalTrials.gov